British PrecisionLife Ltd and the Metrodora Institute have announced to launch clinical trials to improve the diagnosis and therapy of long COVID-related ME/CFS.

Dublin-based ERS Genomics Ltd appointed John E Milad as CEO in the middle of May. He took over from Erik Rhodes, CEO for the last eight years.

Innovate in Bio-Production – Discover how Fermentalg® is revolutionizing the natural food ingredient industry using the power of microalgae.

German-Portuguese biotech start-up MicroHarvest GmbH and a Munich-based pet food manufacturer want to launch the first dog snack made by single cell protein.

AC Immune and Takeda have inked an exclusive option license agreement for ACI-24.060, a first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression.

Dale Levitzke has been appointed as CEO of Sphere Fluidics. He follows CEO and co-founder Dr Frank F. Craig, who announced his retirement after 14 years leading the company.

Swiss antibody specialist Memo Therapeutics AG has added CHF20m to  its Series C financing, bringing the total amount raised in the funding round to CHF 45 million.

More than 900 experts from clusters and the EU Commission discussed at the sold-out 9th European Cluster Conference what cluster policy is needed to make Europe a world leader in prioritised technology fields  such as the green and digital transitions and biotechnology.

Danish CDMO 21st.BIO A/S has unveiled a new pilot plant facility to accelerate scaling of biotech processes ranging from food and beverages, agriculture, biomaterials, and biopharma.
  

  

Single-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.